A pharmaceutical-process-management startup a day keeps the FOMO away.
Startup of the Year | Daily Dealflow | Powered by ESTABLISHED

Startup of the Year: Daily Dealflow 

The Daily Dealflow™ delivers one vetted startup to your inbox every work day.
 
Startup of the Year™ is a global competition, worldwide community, and resource for founders. We discover and support the most promising and innovative startups from around the world through #DailyDealflow, #SOTYPodcast, events, and more.

CherryCircle Software, Inc.

CherryCircle has developed a SaaS platform to rapidly advance digital maturity for pharmaceutical and biotech manufacturing.
CherryCircle's flagship product, QbDVision, is a SaaS solution developed to accelerate therapies to patients by deploying the latest digital, automation, and AI-based technologies that reduce the time and cost of product development without sacrificing product quality.
 
QbDVision allows for the comprehensive management of pharmaceutical process development and validation tracking requirements and risks using science-based justifications supported by data and analytics.

What's Innovative About Their Solution?

QbDVision's competitive advantage is its structured data framework simplifying data collection and automating compliance with industry best practices and regulatory requirements. While some solutions focus on risk assessment and others focus solely on the manufacturing process, QbDVision is the only solution fully integrating and linking product requirements, process requirements, manufacturing data, suppliers, testing strategies, and more into one platform. Once a comprehensive data set is aggregated and contextualized within a single, cloud-based environment, it can be used for manufacturing decision support over the entire development lifecycle. 
Twitter
LinkedIn

📍 Location

Austin, TX

⚙️ Product Stage

Full Release

🏭 Industries

Pharmaceutical, Biotech, Medical Device, Diagnostics

🤑 Fundraising Status

Active term sheet

💸 Total Funding
To Date

>$1.5MM

🙌 Executive Demographics

Minority, Female

Big Wins

  • Currently has 15 customers and $200K in contracts in the first six months of 2020, which include pilot programs with two multinational pharma companies
  • Collaborating with the Center for Advanced Manufacturing in Glasgow, Scotland and with Accenture Life Sciences

Watch the video

Download the deck

Contact the Founder:

Yash Sabharwal

yash@cherrycirclesoftware.com

Subscribe
Submit your Startup
Past Issues
Further Your Passion For Startups
 
The Startup of the Year Podcast raises the bar for startups around the world by providing further insight on the emerging companies featured in our Daily Dealflow newsletter and by highlighting newsworthy stories and global trends affecting the startup ecosystem.
Subscribe Today
The Daily Dealflow is made possible thanks to the support of our amazing partners.
Do you travel for business? American Airlines® has a free, special offer for our friends – companies who enroll in their Business Extra program can earn up to 600 bonus Business Extra points. The program allows your travelers to earn their AAdvantage® miles while collectively earning Business Extra points for the business.
ESTABLISHED
Startup of the Year is powered by Established, a consultancy focused on helping organizations with their innovation, startup, and communication strategies.
 
Created by the talent responsible for building the Tech.Co brand (acquired by an international publishing company), we're leveraging decades of experience to help our collaborators further (or create) their brand & accomplish their most important goals.
Facebook Twitter Instagram LinkedIn
Established, LLC is not a broker-dealer and cannot provide assurances and makes no representations or warranties as to the timing or price terms for any purchase or sale of early-stage company equity. Nothing contained in this email constitutes investment, legal, tax or other advice. No information or statements contained in this email should be relied upon in making an investment or different decision. You should review all risks and consult all applicable professionals when making any investment decisions. Information and statements contained within this email and any attachments are solely for informational purposes and does not constitute an offer to sell or a solicitation to buy any securities.

[Sender_Name]

[Sender_Address], [Sender_City], [Sender_State] [Sender_Zip]

Unsubscribe - Unsubscribe Preferences